New Delhi, May 2 -- Days after vaccine manufacturer AstraZeneca admitted that its Covid-19 vaccine can cause a rare side-effect TTS (Thrombosis with Thrombocytopenia Syndrome), parents of a woman, who was administered Covishield, the vaccine's Indian variant, have decided to move court against Serum Institute of India (SII), the Pune-based firm that developed and manufactured Covishield in the country.

The victim, Karunya, died in July 2021 after taking the shot, India Today reported. The national committee set up by the Union government, however, concluded that the evidence to link her demise with the vaccine was "insufficient."

In light of the latest revelations, Venugopalan Govindan, the victim's father, will now filed a writ petitio...